Archives20242023202220212020201920182017201620152014201320122011 April 23, 2018Immupharma PLC confident on Lupuzor’s™ future Read More April 19, 2018Holding in company Read More April 18, 2018Holding in company Read More April 17, 2018Top line results of Lupuzor™ Pivotal Phase III Trial Read More March 28, 2018Appointment of Joint Broker Read More March 23, 2018Lupuzor™ ‘database lock’ confirmed for 6 April 2018 Read More February 15, 2018London Investor Evening – Monday 26 February 2018 @ 6pm Read More February 08, 2018Holding in Company Read More February 05, 2018Notification of Major Interest – Lanstead Increases Holding to over 5% Read More January 24, 2018Successful Placing to Raise £10 Million Read More January 18, 2018Completion of Lupuzor™ Pivotal Phase III Study and Initiation of Follow Up Study Read More November 28, 2017Update on Lupuzor™ Pivotal Phase III Study Read More 1…1213141516…22
January 18, 2018Completion of Lupuzor™ Pivotal Phase III Study and Initiation of Follow Up Study Read More